Applications of D-2-Nitrophenylalanine in Industrial Manufacturing

D-2-Nitrophenylalanine serves as a specialty amino acid intermediate in advanced chemical synthesis due to its functionalized aromatic ring and chiral configuration. As a manufacturer, we supply high-purity grades for established industrial sectors leveraging its unique structural properties. Below we detail specific, real-world downstream application scenarios with corresponding compliance and operational criteria.

1. Active Pharmaceutical Ingredient (API) Synthesis for Peptidomimetics

Leading pharmaceutical manufacturers utilize D-2-Nitrophenylalanine as a protected amino acid building block in solid-phase and solution-phase peptide synthesis, especially for drug candidates targeting enzyme inhibition and receptor modulation. The nitro group provides distinctive electronic effects for structure-activity relationship studies, and its D-configuration expands the chemical diversity in peptide backbone modifications. Precision in chirality and purity is critical, as the resulting APIs must comply with rigorous global pharmacopeial standards. Production involves its incorporation during SPPS chain elongation, generally following Fmoc or Boc protection routes, with subsequent deprotection and coupling to yield bioactive oligopeptides eligible for clinical development.

Industry compliance standards

• U.S. FDA cGMP (21 CFR 210/211)
• ICH Q7 for Active Pharmaceutical Ingredients
• European Pharmacopoeia monographs (where applicable)
• ISO 9001:2015 for chemical quality management

Typical usage ratio

• 5–15 mol% relative to total amino acids in target peptide; exact ratio depends on desired sequence modification and biological function study.

Downstream process integration

• Direct dosing into automated solid-phase peptide synthesizers during elongation cycles, post-resin loading.
• Manual addition in solution-phase fragment coupling following deprotection of orthogonal groups.

Final product types

• Investigational new drug (IND) peptide candidates
• Enzyme inhibitor libraries
• Laboratory-grade peptidomimetic reference standards
• Custom peptide-based small molecule therapeutics

2. Chiral Building Block in Agrochemical Active Compound Development

Multi-national agrochemical companies employ D-2-Nitrophenylalanine as a precursor in the synthesis of chiral pesticide and herbicide active ingredients. Its stereochemistry is particularly valuable for introducing non-natural amino acid motifs that improve the environmental stability or biological selectivity of agrochemical leads. Manufacturing lines require strict traceability and separation from general process streams to maintain compliance. Downstream processes often initiate with amide bond formation or nitro group transformations to customize mode-of-action profiles.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 17025 for chemical analytical laboratories
• Environmental Protection Agency (EPA) pesticide registration requirements (40 CFR Part 158)

Typical usage ratio

• 1–8 wt% as precursor per kilo of active agrochemical ingredient; value adjusted based on required chiral enrichment and conversion efficiency in target molecule synthesis.

Downstream process integration

• Initial charge in amide-bond formation during target compound assembly.
• Intermediate in the derivatization chain for nitro to amine reduction steps.

Final product types

• Chiral selective herbicide actives
• Peptide-mimetic pesticide molecules
• Research-grade agrochemical intermediates
• Field-level bioassay samples

3. Optical Probe Synthesis in Biochemical Diagnostic Reagents

D-2-Nitrophenylalanine finds specialized use in the design and production of optical probes and enzyme substrates for in vitro diagnostics. Its chromophoric nitrophenyl group enables precise monitoring of protease and peptidase activity in clinical and research assay kits. This application requires the amino acid to meet stringent analytical purity and low endotoxin standards to ensure reproducible optical readouts and compatibility with regulated laboratory workflows.

Industry compliance standards

• ISO 13485:2016 for medical device and diagnostic reagent manufacturing
• IVDR (EU 2017/746) for diagnostic reagents in European markets
• CLSI guidelines for in vitro diagnostic assays
• USP Analytical Reagent Grade requirements

Typical usage ratio

• 2–10 mol% as substrate component per diagnostic assay batch; adjusted by fluorometric or colorimetric assay sensitivity and detection limits.

Downstream process integration

• Coupling with chromogenic or fluorogenic reporters through peptide synthesis steps.
• Integration into assay lyophilization and fill-finish operations for test kits.

Final product types

• Protease cleavage optical assay kits
• Colorimetric enzymatic diagnostic reagents
• Clinical research-grade substrate panels
• Custom biochemical detection probes

4. Custom Amino Acid Source for Life Science Research & Protein Engineering

Academic institutions and bioscience research companies utilize D-2-Nitrophenylalanine for site-specific protein engineering and high-throughput screening of non-canonical amino acid incorporation. Its structural uniqueness enables researchers to study protein folding, stability, and enzyme-substrate specificity in mechanistic studies. We manufacture research-grade lots to support such advanced scientific demand, with careful attention to contamination control, batch consistency, and compatibility with molecular biology workflows. Usage ratios are determined experimentally based on cell expression host, tolerance for analog substitution, and study design.

Industry compliance standards

• ISO 9001:2015 for research chemical production
• Institutional biosafety and chemical hygiene protocols
• Sigma-Aldrich or equivalent laboratory grade specifications

Typical usage ratio

• 0.01–0.2 g/L as non-canonical amino acid supplement in culture medium or reaction buffer; exact level varies with protein production system and substitution frequency.

Downstream process integration

• Immediate addition to cell-free protein synthesis platforms or E. coli-based engineered codon systems for residue-specific incorporation.
• Direct use in in vitro protein folding or refolding studies.

Final product types

• Recombinant proteins carrying D-2-Nitrophenylalanine residues
• Functionalized enzyme libraries for mechanistic evaluation
• Proteomics standards for mass spectrometry calibration
• Academic research tools in protein design